DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
The following is a non-final, first office action on the merits, in response to application filed 2/22/2024. Claims 1-20 have been examined and are currently pending.
Priority
Acknowledgment is made of applicant's claim for a provisional application filed on 2/22/2024. The Applicant claims benefit of continuation of PCT/US2022/042026, filed on 8/30/2022.
Response to Amendment
The amendment filed on 2/22/2024 cancelled no claim. No claim was previously cancelled. New claim 13-20 is added. Claim 3-11 has been amended. Claims 1-20 are considered and pending.
Information Disclosure Statement
The information disclosure statement (IDS) submitted on 2/22/2024, 5/30/2025, 7/7/2025 follows the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefore, subject to the conditions and requirements of this title.
Claims 1-20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more.
Alice Corp. also establishes that the same analysis should be used for all categories of claims, regardless of a system/apparatus, a method, or a product claim.
The claimed invention (Claims 1-20) is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. The claim(s) recite(s) abstract ideas including “Certain Methods of Organizing Human Activity”, “an idea “of itself”, which have been identified/found by the courts as abstract ideas in new 101 memos of the subject matter eligibility in here (https://www.uspto.gov/patent/laws-and-regulations/examination-policy/subject-matter-eligibility) including 2019 Revised Patent Subject Matter Eligibility Guidance. This judicial exception is not integrated into a practical application because it does not impose any meaningful limits on practicing the abstract idea. The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because it/they is/are recited at a high level of generality and/or are recited as performing generic computer functions routinely used in the computer applications:
Independent claim 15 (Step 2A, Prong I): is directed to multiple abstract ideas including “Certain Methods of Organizing Human Activity”, and “Mental process”.
Claim 1, Steps of,
(a) obtaining a tissue sample from a kidney,
(b) measuring expression levels of one or more predictive genes in said sample,
(c) measuring expression levels of one or more housekeeping genes in said sample,
(d) calculating differences in expression levels measured for the one or more predictive genes versus expression levels measured for the one or more housekeeping genes, and
(e) calculating a graft function risk score based on the differences calculated in (d), wherein the graft function risk score is calculated using the following formula (I) graft function risk score = bo + bi(Xi) + b2(X2) + ... bp(Xp) (I) wherein bo is the intercept in a logistic regression model, wherein each bi-p is a regression coefficient for each independent value Xi-p, and wherein each Xi-p is the calculated difference in expression level measured for one predictive gene versus expression level measured for one or more housekeeping genes, and p is the number of predictive genes assayed in the tissue sample.
fall within “Certain Methods of Organizing Human Activity” grouping of abstract idea because these steps recite “obtaining a tissue sample, measuring expression level, calculating difference in expression levels, calculating a graft function risk score…“, which are human activities and/or interactions between users/people/devices and therefore, certain methods of organizing human activity which encompasses both certain activity of a single person, certain activity that involves multiple people, and certain activity between a person and a computer.
In addition, claim 1, steps mentioned above also falls within the abstract “Mental Processes” grouping of abstract ideas since these limitation covers performance of the limitations in the mind. For example, a human being can observe/obtain/collect a tissue sample, can observe/measure expression levels, can observe/calculate difference in expression levels, can observe calculate risk score by using mathematical formulas”.
In addition, claim 1 is substantially drawn to mathematical concepts and computation. As to the providing and developing limitations, they are used similarly to computations using math equations/formulas to do so.
If a claim limitation, under its broadest reasonable interpretation, covers mathematical concepts, then it falls within the "(a) Mathematical concepts" grouping of abstract ideas (2019 PEG Step 2A, Prong One: Abstract Idea Grouping? = Yes, (a) Mathematical concepts).
Independent claim 1, Step 2A (Prong II): Accordingly, the claim recites an abstract idea(s) as pointed out above. This judicial exception(s) is/are not integrated into a practical application. In particular, the claim recites no additional elements that are significant more than the abstract ideas. There is no machine/hardware/computer to perform the abstract steps mentioned above. Nothing in the claim element precludes the step from practically being performed in the mind or by paper and pen and is simply organized information through human activity or merely mental tasks, and is part of, or a related, judicial exception and does not meaningfully limit the application of the identified judicial exception, and as such does not constitute significantly more.
There is no specificity regarding any technology, just broadly, execute the programming instructions to receive data, analyze/measure data, calculate data. There are no additional elements, for example, hardware processor of a machine to perform all the steps at all. The steps are mainly collecting data, measuring data, and calculating data. The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception. Accordingly, there is neither improvement to another technology or technical field nor improvement to the functioning of the computer itself and does not integrate the abstract idea into a practical application because it does not impose any meaningful limits on practicing the abstract idea.
Independent claim 1, (step 2B):
There are no additional elements that are significant more than the abstract ideas.
The components are merely recited at a high level of generality and/or is recited as performing generic computer functions routinely used in the computer applications; thus, they are not significantly more than the identified abstract idea. Generic sensor/computer components recited as performing generic sensing/computer functions that are well-understood, routine and conventional activities amount to no more than implementing the abstract idea with a computerized system. The use of generic computer components to receive/compute/send/display information over communication network/internet does not impose any meaningful limit on the computer implementation of the abstract idea. At best, the claim(s) are merely providing an environment to implement the abstract idea. (see analysis in claim 1).
Dependent claims 3-12, are merely add further details of the abstract steps/elements recited in claim 1, without including an improvement to another technology or technical field, an improvement to the functioning of the computer itself, or meaningful limitations beyond generally linking the use of an abstract idea to a particular technological environment. Therefore, dependent claims 3-12 are also non-statutory subject matter.
Similarly, independent method claim 2 is rejected under Alice 101 rejection, (see analysis in claim 1).
Dependent claims 13-20, merely add further details of the abstract steps/elements recited in claim 2, without including an improvement to another technology or technical field, an improvement to the functioning of the computer itself, or meaningful limitations beyond generally linking the use of an abstract idea to a particular technological environment. Therefore, dependent claims 13-20 are also non-statutory subject matter.
Viewed as a whole, the claims (1-20) do not provide meaningful limitations to transform the abstract idea into a patent eligible application of the abstract idea such that the claim(s) amounts to significantly more than the abstract idea itself.
Thus, the claims do NOT recite limitations that are “significantly more” than the abstract idea because the claims do not recite an improvement to another technology or technical field, an improvement to the functioning of the computer itself, or meaningful limitations beyond generally linking the use of an abstract idea to a particular technological environment.
Thus, the claimed invention does not provide 'significantly more' than the abstract idea and is non-statutory subject matter.
Prior art Rejections
Independent claims 1, 2, recite a combination of limitations that has Not been found as define over prior art of record (the combination of Murphy et al. (US 2017/0137883), Murphy et al. (US Patent 11,572,589), Murphy et al. (US Patent 11,674,181), Skog, Johan et al. (WO 2009/100029 A1), Murphy, Barbara (WO 2019204267 A1), Sarwal, Minne (WO 2010083121 A1),
which was directed towards the entirety of the claimed subject matter and was the best reference known to one of ordinary skill in the art to address the instant claims, and
NPL1-- von Moos S, Akalin E, Mas V, Mueller TF. Assessment of Organ Quality in Kidney Transplantation by Molecular Analysis and Why It May Not Have Been Achieved, Yet. Front Immunol. 2020 May 12;11:833. doi: 10.3389/fimmu.2020.00833. PMID: 32477343; PMCID: PMC7236771.
NPL2-- McGuinness D, Leierer J, Shapter O, Mohammed S, Gingell-Littlejohn M, Kingsmore DB, Little AM, Kerschbaum J, Schneeberger S, Maglione M, Nadalin S, Wagner S, Königsrainer A, Aitken E, Whalen H, Clancy M, McConnachie A, Koppelstaetter C, Stevenson KS, Shiels PG. Identification of Molecular Markers of Delayed Graft Function Based on the Regulation of Biological Ageing. PLoS One. 2016 Jan 6;11(1):e0146378. doi: 10.1371/journal.pone.0146378. Erratum in:
NPL3— Mas VR, Archer KJ, Dumur CI, Scian MJ, Suh JL, King AL, Wardius ME, Straub JA, Posner MP, Brayman K, Maluf DG. Reduced expression of inflammatory genes in deceased donor kidneys undergoing pulsatile pump preservation. PLoS One. 2012;7(4):e35526. doi: 10.1371/journal.pone.0035526.
All fail to teach all the claimed features.
Allowable Subject Matter
Upon further search and consideration, it is found that claim 1-20 is allowable subject to outstanding Alice 101 rejection.
As allowable subject matter has been indicated, applicant's reply must either comply with all formal requirements or specifically traverse each requirement not complied with, and pending remedy to outstanding issues cited above. See 37 CFR 1.111(b) and MPEP § 707.07(a).
The prior art made of record and Not relied upon is considered pertinent to applicant’s disclosure.
Sarwal (US 2016/0348174, teaches diagnosing acute rejection of renal transplants using the gene expression profile of sets of classifier genes, regardless of independent of external confounders such as recipient age, transplant center, RNA source, assay, cause of end-stage renal disease, co-morbidities, immunosuppression usage…).
Strom et al. (US 20070122806, teaches assessing patients who have received a transplant and reagents, optionally packaged as kits or organized as arrays, and found that clinical parameters available at the time of transplantation correlate with decreased graft health and can be considered in combination with gene expression to evaluate a patient's risk for an adverse outcome).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SUN M LI whose telephone number is (571)270-5489. The examiner can normally be reached on Mon-Thurs, 8:30am-5pm. Fax is 571-270-6489.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kambiz Abdi, can be reached on 571-272-6702. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SUN M LI/Primary Examiner, Art Unit 3685